NRIX (Nurix Therapeutics) Days Inventory: (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NRIX Nurix Therapeutics Inc NRIX
59 GF Score
Price $25.41
GF Value $7.84
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nurix Therapeutics Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Nurix Therapeutics's Average Total Inventories for the three months ended in May. 2026 was $0.00 Mil. Nurix Therapeutics's Cost of Goods Sold for the three months ended in May. 2026 was $3.85 Mil. Hence, Nurix Therapeutics's Days Inventory for the three months ended in May. 2026 was 0.00.

The historical rank and industry rank for Nurix Therapeutics's Days Inventory or its related term are showing as below:

NRIX's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.66
* Ranked among companies with meaningful Days Inventory only.

Nurix Therapeutics's Days Inventory stayed the same from May. 2025 () to May. 2026 ().

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nurix Therapeutics's Inventory-to-Revenue for the three months ended in May. 2026 was 0.00.


Nurix Therapeutics  (NAS:NRIX) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nurix Therapeutics's Inventory Turnover for the three months ended in May. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nurix Therapeutics's Inventory to Revenue for the three months ended in May. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Nurix Therapeutics Days Inventory Related Terms


Nurix Therapeutics Days Inventory Historical Data

* Premium members only.

The historical data trend for Nurix Therapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nurix Therapeutics Days Inventory Chart

Nurix Therapeutics Annual Data
Trend Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Days Inventory
Get a 7-Day Free Trial - - - - -

Nurix Therapeutics Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NRIX vs ATAI, SLS, VRDN: Days Inventory Comparison

For the Biotechnology subindustry, Nurix Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nurix Therapeutics Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nurix Therapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Nurix Therapeutics's Days Inventory falls into.


NRIX
59GF Score
Nurix Therapeutics Inc NRIX
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nurix Therapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nurix Therapeutics's Days Inventory for the fiscal year that ended in Nov. 2025 is calculated as

Days Inventory (A: Nov. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Nov. 2024 ) + Total Inventories (A: Nov. 2025 )) / count ) / Cost of Goods Sold (A: Nov. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 18.856*365
=0 / 18.856*365
=0.00

Nurix Therapeutics's Days Inventory for the quarter that ended in May. 2026 is calculated as:

Days Inventory (Q: May. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Feb. 2026 ) + Total Inventories (Q: May. 2026 )) / count ) / Cost of Goods Sold (Q: May. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 3.85*365 / 4
=0 / 3.85*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Nurix Therapeutics (NRIX) Overvalued in 2026?

Based on GuruFocus' analysis, Nurix Therapeutics stock appears to be overvalued. The current stock price of $25.41 is trading 224.1% above its estimated GF Value™ of $7.84. GuruFocus considers Nurix Therapeutics to be Significantly Overvalued.

Key valuation signals for NRIX:

  • Days Inventory:
  • GF Value™: $7.84 vs. price of $25.41 (224.1% above fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the NRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nurix Therapeutics Business Description

Address 1600 Sierra Point Parkway, Brisbane, CA, USA, 94005
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
59GF Score

Get the complete analysis for NRIX

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.41
Price
$7.84
GF Value